TickerFacts.

Anixa Biosciences Inc (ANIX): EPS (Diluted)

Annual figures by period end, from SEC filings.

Stock splits: 1-for-25, first reflected in a filing dated 2015-08-18. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2023-10-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

-$0.34
Year ended 2025-10-31
$0.452022-10-31: $0.452023-10-31: -$0.322024-10-31: -$0.392025-10-31: -$0.34-$0.34
2022-10-31 EPS (Diluted) (USD per share) 2025-10-31
Period endedEPS (Diluted)Change YoYSource filing
2025-10-31-$0.34n/m2026-01-12, From 2024-11-01
2024-10-31-$0.39n/m2026-01-12, From 2023-11-01
2023-10-31-$0.32n/c2025-01-10, From 2022-11-01
2022-10-31$0.45n/a2024-01-16, From 2021-11-01

EPS (Diluted) at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEPS (Diluted)Change YoY
Anixa Biosciences Inc (ANIX)2025-10-31-$0.34n/m
Aprea Therapeutics, Inc. (APRE)2025-12-31-$1.93n/m
Aditxt, Inc. (ADTX)2025-12-31-$1153.83n/m
Synlogic, Inc. (SYBX)2025-12-31-$0.08n/m
Tempest Therapeutics, Inc. (TPST)2025-12-31-$6.33n/m
Lipocine Inc. (LPCN)2025-12-31-$1.69n/a
Cingulate Inc. (CING)2025-12-31-$4.44n/m
Cellectar Biosciences, Inc. (CLRB)2025-12-31-$8.35n/m
Impact Biomedical Inc. (IBO)2025-12-31-$0.38n/m

Compare ANIX, APRE, ADTX, SYBX side by side · Screen every company in Pharmaceutical Preparations ↗